جست‌وجوی استاد و پژوهشگر

Francesca Stradoliniمشاهده پروفایل

مدرس

• Bioelectronics
• IoT for Medical Monitoring
• Anesthesia Delivery Systems
• +۳ مورد دیگر

Francesca Stradolini is a Lecturer at École Polytechnique Fédérale de Lausanne (EPFL), affiliated with the Electrical Engineering Doctoral School (EDEE). She holds a PhD in Electrical Engineering from EPFL (2018), with prior education in Bio Engineering and Neuroscience from the University of Genoa (2012, 2015). Her current work focuses on R&D engineering for medical devices, emphasizing system lifecycle management, human factors engineering, and compliance with CE/FDA regulations. As an invited guest, she contributes to usability engineering education and interdisciplinary research at EPFL. PhD: IoT Bio-Electronic Multi-Panel Device for On-line Monitoring of Anaesthesia Delivery (EPFL, 2018) MSc: Bio Engineering (University of Genoa, 2015) BSc: Bio Engineering (University of Genoa, 2012) Her research spans bioelectronics, IoT-enabled medical monitoring, and electrochemical sensor development for clinical applications. Key areas include anesthesia delivery systems, wearable diagnostics, implantable devices, and human factors engineering. Her work integrates fluidic systems, noble metal nanostructures, and open-source hardware (e.g., Raspberry Pi) to address challenges in traceability, fouling mitigation, and pharmacokinetic modeling. Scientific recognition includes the Ville de Lausanne Award (2019) , EPFL Outstanding PhD Thesis Distinction (2018) , and a Best Paper Award at MOBIHEALTH (2016) . She has published extensively in journals like IEEE TBIOCAS, Sensors and Actuators B, and IEEE Sensors Journal, with collaborative studies on propofol monitoring, carbon nanoallotrope drug detection, and implantable sensor validation. Her technical expertise includes managing medical device development lifecycles, designing IoT architectures for intensive care, and optimizing electrochemical sensors for stability in undiluted biological fluids. She has contributed to conferences such as IEEE BioCAS, ISCAS, and MOBIHEALTH, focusing on translational studies in personalized medicine and 3D-printed medical systems.

Michael McAlpineمشاهده پروفایل

استاد

• 3D Printing
• Nanotechnology
• Biomedical Engineering
• +۴ مورد دیگر

Michael McAlpine is a Professor in the Mechanical Engineering department at the University of Minnesota . He also holds affiliations with the Biomedical Engineering and Electrical and Computer Engineering departments. His research focuses on 3D printing functional materials & devices , Nanoscale inks , Biomedical devices , Bioelectronics , and Flexible Microsystems . Research Interests : 3D Printing, Biomedical Engineering, Nanotechnology, Flexible Electronics, Microfluidics Labs : ME 361/363 Contact : mcalpine@umn.edu , (612) 626-3303, ME 117 Recent Research Trends include 3D Printed Biomedical Devices , Flexible Electronics , and Bioprinting Applications . His work spans from Spinal Organoid Formation to Programmable Drug Release Capsules . Scientific Award : Circulation Research 2020 Best Manuscript Award

Robert J. Hamersمشاهده پروفایل

استاد

• Electrochemistry
• Nanotechnology
• Materials Science
• +۹ مورد دیگر

Robert J. Hamers is a Professor of Chemistry and the Steenbock Professor of Physical Science at the University of Wisconsin-Madison . He serves as the Director of the Center for Sustainable Nanotechnology , a multi-institutional collaboration, and is a Senior Editor for Accounts of Chemical Research . Additionally, he co-founded the startup Silatronix, Inc. and leads the ACS/UW-Madison Bridge to the Chemistry Doctorate Program . B.S. in Chemistry, University of Wisconsin-Madison (1980) Ph.D. in Chemistry, Cornell University (1986) Hamers' research focuses on surface chemistry, nanotechnology, and renewable energy , with specific interests in electrochemical energy storage, photoelectron emission mechanisms, and environmental impacts of nanomaterials . His group develops ultra-stable surface chemistries for energy devices and investigates charge-transfer processes at material interfaces . Recent publications highlight advances in diamond-based materials , organosilicon electrolyte additives , and environmental fate of nanomaterials . Scientific recognitions include the Wisconsin Distinguished Professor title. His work bridges fundamental surface science with applied technologies through collaborations with academic institutions, national laboratories, and industry partners like Dow Chemical . The Hamers Group actively trains graduate students and postdoctoral researchers in multidisciplinary approaches.

Matthias Mannمشاهده پروفایل

استاد

• Mass Spectrometry
• Proteomics
• Systems Biology
• +۶ مورد دیگر

Professor Matthias Mann is a world-leading scientist serving as Director of the Proteomics and Signal Transduction department at the Max Planck Institute of Biochemistry in Martinsried, Germany, and Director of the Proteomics department at the Novo Nordisk Foundation Center for Protein Research, Faculty of Health Sciences, University of Copenhagen, Denmark. With an h-index exceeding 277 and over 350,000 citations, he is recognized as the highest cited German researcher and one of the most influential scientists globally in proteomics. His educational background includes: Ph.D. in Chemical Engineering from Yale University (1988) Master's Degree in Physics from Georg August University Göttingen (1984) Bachelor's of Arts in Mathematics from Georg August University Göttingen (1982) Professor Mann's research focuses on advancing mass spectrometry-based proteomics to understand biological systems at the protein level. His work spans technological developments in mass spectrometry, bioinformatics and computational analysis, signal transduction and posttranslational modifications, and clinical proteomics applications for disease diagnosis and treatment. The Mann lab has pioneered groundbreaking methods like SILAC for quantitative proteomics and MaxQuant for proteome data analysis. Their vision is to translate proteomics knowledge into clinical practice for predictive, diagnostic, and preventive medicine, with recent work focusing on AI-guided platforms for analyzing proteomes from minimal tissue samples. Analysis of Professor Mann's recent publications reveals a strong trend toward clinical applications of proteomics, particularly in cancer research, metabolic diseases, and neurodegenerative disorders. His work increasingly integrates spatial proteomics, single-cell resolution techniques, and artificial intelligence approaches to uncover disease mechanisms and identify potential biomarkers, with a clear shift from basic technology development toward direct clinical applications and personalized medicine. Professor Mann has received numerous prestigious awards throughout his career: 2025: Elected member of the American National Academy of Sciences 2024: Dr. H.P. Heineken Award for Biochemistry and Biophysics 2023: Otto Warburg Medal 2019: Nominated member of the Bavarian Academy of Sciences 2013: Elected member of Leopoldina German National Academy of Sciences 2012: Körber European Science Award, Louis-Jeantet Foundation Prize for Medicine, Ernst Schering Prize, and Leibniz Prize Professor Mann leads a highly collaborative research team involved in multiple international networks including the Bill & Melinda Gates Foundation, Michael J. Fox Foundation for Parkinson's Research, CLINSPECT-M, and Munich Heart Alliance. His lab has mentored numerous successful researchers, with several former postdocs receiving prestigious ERC Starting Grants. The Mann group has developed innovative clinical proteomics pipelines for analyzing archived tissue specimens and body fluids, aiming to identify protein markers for early detection of diseases such as diabetes and cancer. The Mann lab operates across two major research centers with state-of-the-art mass spectrometry facilities. Their Clinical Knowledge Graph platform integrates multi-omics data with extensive metadata, creating an ecosystem for machine learning applications in proteomics. Current research focuses on developing highly sensitive methods that can profile thousands of proteins from minimal cell samples, enabling the identification of critical disease-related proteins and supporting the development of individualized therapies.

Richard Fairمشاهده پروفایل

استاد

• Microfluidics
• Electrowetting Technology
• Lab-on-a-Chip Systems
• +۷ مورد دیگر

Dr. Richard Fair is the Lord-Chandran Distinguished Professor of Engineering at Duke University, with a career spanning semiconductor physics, digital microfluidics, and lab-on-a-chip systems. His research group collaborates with faculty across Duke, Harvard, and Stanford in bioengineering, genomics, and environmental science to develop applications-driven microfluidic platforms. Ph.D. in Electrical and Computer Engineering, Duke University (1969) B.S.E.E., Duke University (1964) M.S.E.E., Pennsylvania State University (1966) Research interests focus on electrowetting-based microfluidics for biosensing, diagnostics, and synthetic biology applications. Key innovations include adaptive droplet routing , magnetic bead manipulation , and integrated optical sensors for real-time analyte detection in environmental and medical contexts. Recent publications emphasize deep reinforcement learning for biochip automation, fluorescent nucleosome detection , and inorganic ion analysis in aerosols. Collaborations with institutions like Advanced Liquid Logic and NSF-funded projects highlight his interdisciplinary approach. IEEE Third Millennium Medal (2000) Solid State Science and Technology Award (Electrochemical Society, 2003) Gordon E. Moore Medal (2009) Fellow, IEEE and Electrochemical Society Grants include NSF awards with Nan Jokerst and Krish Chakrabarty for adaptive lab-on-a-chip optical control, DARPA funding for genomic engineering platforms, and collaborations with the Desert Research Institute on airborne particle sensing. His lab develops scalable solutions for environmental monitoring, clinical diagnostics, and synthetic biology applications.

Jered Haunمشاهده پروفایل

دانشیار

• Biomedical Engineering
• Molecular Medicine
• Nanotechnology
• +۴ مورد دیگر

Jered Haun is an Associate Professor at the Samueli School of Engineering , University of California, Irvine , with joint appointments in Biomedical Engineering , Chemical and Biomolecular Engineering , and Materials Science and Engineering . Based in 3107 Natural Sciences II , his research focuses on developing nanoengineering and molecular medicine technologies to improve disease diagnosis and treatment. Email: jered.haun@uci.edu Phone: (949) 824-1243 Research Interests include: Nanomaterial Probes for molecular profiling and disease detection Microfabricated Platforms for cell analysis and tissue processing Targeted Delivery Carriers that interact with unique disease molecules Technologies employed in his lab encompass: Fluorescence imaging and MRI enhancements Bioorthogonal chemistry and nanosensor development Micro-NMR for tumor analysis Quantum dot-based detection systems Awards include: NIH National Cancer Institute's Innovative Molecular Analysis Technologies Funding The Haun Laboratory actively recruits graduate and undergraduate students for projects related to nanoengineering, molecular medicine, and microfluidic device development.

• Biomaterials
• Tissue Engineering
• Regenerative Medicine
• +۱۲ مورد دیگر

Professor Hala Zreiqat AM is a leading biomedical engineer at The University of Sydney , serving as the Director of the ARC Training Centre for Innovative BioEngineering . A Fellow of all major Australian academies (AAS, ATSE, FAHMS, FRSN), she develops 3D printed bioceramics for bone regeneration while championing diversity through initiatives like the IDEAL Society and BIOTech Futures mentorship program. Her work bridges academia, clinical practice, and industry in musculoskeletal research . Research Focus: Her lab creates synthetic bone scaffolds that mimic natural bone architecture, strength, and porosity, enabling non-rejected bone regeneration via patient-matched implants. Key applications include orthopaedic, dental, and maxillofacial repair , with over $18M in competitive funding and multiple patents. Current projects explore AI-driven scaffold performance prediction and anti-senescence strategies for aging-related bone loss. Scientific Trends: Recent publications highlight 3D printed nanovoxelated ceramics , antisenescence biomaterials , and multifunctional theranostic platforms . Her team integrates machine learning for scaffold design, atom probe tomography for interface analysis, and two-photon imaging for cellular monitoring in 3D environments. 2021-2022 Fulbright Senior Scholar 2018 NSW Premier's Woman of the Year 2019 Eureka Prize for Innovative Use of Technology Fellow of Australian Academy of Science (2021) Over $18M in research funding Teaching & Leadership: She designed core courses like Tissue Engineering and Nanomaterials in Medicine , mentoring 158 students in 2020 alone. As Chair of CAAR (2020-2023), she strengthens Australia-Arab collaborations. Her lab trains early-career researchers , with alumni now in academia and industry.

• Analytical Chemistry
• Microfluidics
• Biomedical Engineering
• +۲ مورد دیگر

JIANG Xingyu is Chair Professor and Head of the Department of Biomedical Engineering at the Southern University of Science and Technology (SUSTech) . Since 2018 he has led a multidisciplinary team developing advanced micro- and nano-scale tools for analytical chemistry, microfluidics and nanomedicine. Education Postdoctoral Research, Harvard University (2004–2005) Ph.D. in Chemistry, Harvard University (2004) B.S. in Chemistry, University of Chicago (1999) Research Interests Professor Jiang’s research integrates analytical chemistry , microfluidics , biomedical engineering and nanomedicine . His laboratory designs microfluidic chips for point-of-care diagnostics, engineers gold nanoclusters and nanoparticles for antimicrobial and anticancer therapy, and develops soft flexible bio-electronics for neural interfaces and wearable health monitoring. Across 400+ publications, recent work demonstrates a clear trend toward translational nanomedicine : point-of-care viral variant detection, nanoantibiotic strategies against multidrug-resistant bacteria, CRISPR delivery systems for cancer therapy, and conformal electronic tattoos for human-machine interfaces. Scientific Awards & Honours Fellow, American Institute for Medical and Biological Engineering (2020) Fellow, Royal Society of Chemistry (2016) Tencent Science Exploration Award (2019) Chief Scientist, National Key R&D Program (2019–) National Science Fund for Distinguished Young Scholars (2010) Young Investigator Award, Human Frontier Science Program (2007) Research Funding & Teams He currently directs the Nanoscience Laboratory at SUSTech, hosts National Key R&D Program projects as Chief Scientist, and serves on editorial boards of Advanced Healthcare Materials , Lab on a Chip , Nanoscale Horizons , Nanoscale and Nanoscale Advances . The group is actively recruiting post-docs, research professors and technicians across chemistry, materials, biology and medical engineering disciplines.

Michael Baymمشاهده پروفایل

دانشیار

• Microbial Evolutionary Genomics
• Antibiotic Resistance
• Computational Biology
• +۷ مورد دیگر

Dr. Michael Baym is an Associate Professor of Biomedical Informatics at Harvard Medical School with affiliate appointments in Microbiology and the Laboratory of Systems Pharmacology, and as an Associate Member of the Broad Institute. He leads the Baym Lab, which studies microbial evolutionary genomics and antibiotic resistance through a hybrid of experimental, computational, and theoretical approaches. His research focuses on: Antibiotic Resistance Evolution and practical interventions Mobile Genetic Elements (plasmids, phages, transposons) Computational Genomic Algorithms for big data analysis Synthetic Biology tools and technologies Key recent publications explore phage discovery systems , phylogenetic compression of microbial genomes, and RNA-guided gene drives in plasmids. His work is supported by multiple NIH/NIGMS and NSF grants including a MIRA award. Scientific honors include: Packard Fellowship (2018) Pew Biomedical Scholarship (2020) Sloan Research Fellowship (2020) A. Clifford Barger Excellence in Mentoring Award (2021) SSQBio Mentorship Award (2022) The lab actively trains PhD students and postdoctoral fellows with alumni occupying academic and industry positions globally. Current team members include researchers from interdisciplinary backgrounds working at the intersection of experiment, computation, and theory .

• Immunology
• Virology
• Inflammation
• +۵ مورد دیگر

Santiago F. González is a Group Leader at the Institute for Research in Biomedicine (IRB) in Bellinzona, Switzerland, and an extraordinary professor at the University of Italian Switzerland (USI). He earned dual PhDs in microbiology (University of Santiago de Compostela, Spain) and immunology (University of Copenhagen, Denmark), followed by postdoctoral work (2007–2011) at Harvard Medical School's Immune Disease Institute under Michael Carroll. PhD in Microbiology, University of Santiago de Compostela PhD in Immunology, University of Copenhagen His research focuses on immune system dynamics during respiratory viral infections, vaccination, and cancer metastasis. Key areas include influenza recognition , lymph node inflammation , and immune cell behavior in vivo. He pioneered studies on C-type lectin receptors (e.g., SIGN-R1) in viral immunity and epigenetic modulators for inflammation. Recent publications highlight his work in epigenetic drug development , nanovaccines , and computational tools for immune cell tracking. His group uses two-photon intravital microscopy and spatial-temporal modeling to dissect immune responses. Scientific awards include three EU Marie Curie Fellowships (2004–2013), enabling his transition to independent research. His collaborations span Harvard, USI, and European institutions, with grants from the EU and Swiss research bodies. His lab at IRB, established via the 2013 Marie Curie Career Integration Grant , develops novel imaging approaches and therapeutic strategies for infectious and immune-mediated diseases.

Steven A. Soperمشاهده پروفایل

استاد

• Bioanalytical Chemistry
• Microfluidics
• Nanofluidics
• +۷ مورد دیگر

Steven A. Soper is a Foundation Distinguished Professor in the Department of Chemistry and Mechanical Engineering at the University of Kansas. He serves as Director of the NIH-funded Center for BioModular Multi-Scale Systems for Precision Medicine and leads international collaborations with institutions like UNIST in South Korea. His career spans faculty roles at LSU, UNC, and KU, with interdisciplinary research bridging chemistry, biomedical engineering, and materials science. Ph.D. in Bioanalytical Chemistry, University of Kansas (1989) Postdoctoral Fellow, Los Alamos National Laboratory (1991) B.S. in Chemistry and Psychology, University of Nebraska (1980-1982) Research Interests focus on micro-/nanofabricated biochemical analysis systems for clinical diagnostics, particularly circulating tumor cell analysis , cell-free DNA detection , and single-molecule fluorescence applications. His work integrates polymer microfabrication, FRET-based assays, and thermoplastic nanofluidics for cancer, stroke, and infectious disease diagnostics. Scientific Awards include: R&D 100 Award (2010) Shannon Award (NIH) (1994) Distinguished Research Master, LSU (2002) Fellow, AAAS/RSC/SAS (2010) Sutton Family Research Impact Award (2021) Teaching & Collaboration involves mentoring 39 professional-degree recipients, organizing multidisciplinary research teams, and co-teaching courses in Biofluid Mechanics and Nanotechnology . His lab partners with institutions in South Korea and UNC/NCSU, while hosting international students and professionals. Labs & Centers : Leads the Soper Research Group and the Center for BioModular Multi-Scale Systems , which provides access to state-of-the-art nanofabrication tools and collaborative expertise across 12 institutions.

Hong Hanمشاهده پروفایل

استادیار

• Cancer Biology
• Gene Regulation
• RNA Splicing
• +۵ مورد دیگر

Hong Han is an Assistant Professor in the Department of Biochemistry & Biomedical Sciences within McMaster University's Faculty of Health Sciences and a member of the Centre for Discovery in Cancer Research (CDCR). She holds a Canada Research Chair and leads the Han Lab, which focuses on cancer biology, RNA regulation, and innovative high-throughput technologies for therapeutic discovery. Dr. Han earned her Ph.D. from the University of Toronto (2010-2016) and has established herself as a leading researcher in glioblastoma and alternative splicing regulation. Her interdisciplinary research integrates cancer biology, RNA science, and multilayer gene regulation to uncover mechanisms underlying cancer progression and treatment resistance. Her laboratory pioneers integrated technological platforms for large-scale genetic/drug screening and ultra-high-throughput single-cell profiling. The research focuses on three main areas: alternative splicing regulation in cancer (particularly glioblastoma and prostate cancer), multilayer mechanisms of glioblastoma heterogeneity and microenvironment evolution, and multiplexed screening approaches for therapeutic discovery in treatment-resistant cancers. Analysis of Dr. Han's recent publications reveals a strong emphasis on single-cell technologies to characterize glioblastoma heterogeneity, minimal residual disease states, and tumor-immune interactions. Her work increasingly bridges basic RNA biology with translational applications, particularly in developing novel therapeutic strategies targeting splicing networks and immune evasion mechanisms. Canada Research Chair Dr. Han teaches Advanced Techniques in the Biomedical Sciences (BIOCHEM 734). Her research program is supported by multiple funding sources, as evidenced by her extensive publication record in high-impact journals including Nature, Cell, Molecular Cell, and Nature Communications. She employs a comprehensive approach combining in vitro, in vivo, and patient cohort studies with cutting-edge genomic technologies. The Han Lab has developed innovative multiplexed screening platforms that enable simultaneous interrogation of thousands of conditions, ranging from CAR-T cells to small molecule therapeutics. This approach accelerates the discovery of novel cancer targets and therapeutic strategies for treatment-resistant cancers.

Jeannine Baumgartnerمشاهده پروفایل

مدرس

• Nutritional Sciences
• Micronutrients
• Omega-3 Fatty Acids
• +۶ مورد دیگر

Dr. Jeannine Baumgartner is a Lecturer in the Department of Nutritional Sciences at King's College London and an Extraordinary Associate Professor at North-West University, South Africa. She holds an MSc and PhD in Human Nutrition from ETH Zurich, Switzerland. Key Appointments : Lecturer at King's College London (2022–present), Senior Scientist at ETH Zurich (2018–2022), Associate Professor at North-West University (2018). Research Focus : Optimal early-life nutrition for maternal/child health, iron and omega-3 fatty acid interventions, stable isotope methodologies, HIV-metabolic interactions, and mental health-diet links. Her recent work explores iron absorption dynamics in Thai children, maternal iron status in South Africa, and omega-3 fatty acids in depression. She leads an NIHR-funded project to reassess UK iron reference values. Scientific Leadership : Board Member, International Society for the Study of Fatty Acids and Lipids (ISSFAL) Editorial Board, European Journal of Clinical Nutrition

Gregory C. Grayمشاهده پروفایل

استاد

• Infectious Disease Epidemiology
• One Health Approach
• Occupational Disease Transmission
• +۴ مورد دیگر

Gregory C. Gray, MD, MPH, FIDSA is a Professor in Infectious Disease Epidemiology at the University of Texas Medical Branch (UTMB) in Galveston, Texas, with appointments across multiple departments including Internal Medicine (Infectious Diseases), Microbiology & Immunology, and Global Health & Emerging Diseases. Dr. Gray has conducted epidemiological studies of infectious diseases for over 25 years across five continents, with a particular focus on occupational disease transmission, especially respiratory viruses. His research has examined farmers, veterinarians, turkey workers, swine workers, poultry workers, horse workers, cattle workers, hunters, and military personnel. He pioneered the Millennium Cohort Study, a prospective cohort study of approximately 300,000 people projected to continue through 2068, and has led numerous large-scale vaccine trials. As a strong advocate for the One Health approach, Dr. Gray has established One Health centers in the USA, Romania, and China, and developed four graduate programs in One Health (PhD, MHS, and certificates). His recent research focuses on zoonotic spillover events, universal influenza vaccines, and coronavirus detection in agricultural settings, with numerous publications in 2024-2025 addressing H5N1 avian influenza, respiratory virus transmission, and environmental health impacts. Selected honors include: Department of Defense Legion of Merit Medal Secretary of Defense Medal for Outstanding Public Service Medal of Honor from Mongolia's Minister of Health The Peace Medal awarded by the President of Mongolia University of Texas Medical Branch Robert E. Shope, MD Professorship Dr. Gray has authored over 350 peer-reviewed manuscripts cited more than 21,000 times (H-index 76). His current research portfolio includes multiple active grants from the USDA, Fogarty International Center, and private industry focusing on zoonotic disease surveillance, influenza vaccines, and coronavirus detection in agricultural settings. He has mentored numerous students and established international collaborations across six continents.

Philippe Christeمشاهده پروفایل

دانشیار

• Host-Parasite Interactions
• Evolutionary Ecology
• Behavioral Ecology
• +۷ مورد دیگر

Philippe Christe is an Associate Professor in the Department of Ecology and Evolution at the University of Lausanne (UNIL), Faculty of Biology and Medicine. His research centers on host-parasite interactions, with a focus on bats, birds, and their ectoparasites, integrating behavioral, physiological, and genetic approaches. He leads the Christe Group, which investigates evolutionary and ecological dynamics in host-parasite systems, particularly avian malaria and bat-mite relationships. He is actively involved in conservation initiatives, including the Jorat Peri-Urban Nature Park, and collaborates with KORA on human-wildlife interactions. Bachelor's degree in biology, UNIL (1989) PhD in Zoology and Animal Ecology, UNIL (1994) Philippe Christe’s research interests lie at the intersection of parasitology, evolutionary ecology, and conservation biology. He investigates how host defenses evolve in response to parasitic pressures, examining trade-offs between immunity and life history traits such as reproduction and survival. His work often integrates field studies with experimental and molecular techniques. Key model systems include Parus major (great tit) and Culex pipiens in avian malaria, and bat species with their ectoparasitic mites. He also explores broader ecological interactions, including predator-prey dynamics and wildlife conservation in human-modified landscapes. His recent publications reflect a strong emphasis on disease ecology, wildlife conservation, and molecular methods. Articles span topics such as avian malaria transmission, lynx population dynamics, snow leopard behavior, and habitat fragmentation effects on insects. These works employ advanced techniques like DNA metabarcoding, spatial modeling, and long-term monitoring, demonstrating a trend toward interdisciplinary, data-driven ecological research with direct conservation applications. Dubois Foundation Prize for an educational CD-Rom on bats (2004) Communication Award from the Faculty of Biology and Medicine of UNIL (2017) Philippe Christe has supervised numerous PhD and Master’s students, contributing significantly to training the next generation of ecologists and evolutionary biologists. His group collaborates widely with institutions such as the Museum of Zoology in Lausanne and KORA, and participates in large-scale conservation projects involving snow leopards, lynx, and bats. He has been involved in research grants related to host-parasite coevolution, wildlife monitoring, and conservation strategies. His leadership in establishing the Jorat Peri-Urban Nature Park and involvement in the UNIL Interdisciplinary Center for Mountain Research highlight his commitment to applied science and environmental stewardship. He leads the Christe Group, which conducts research on host-parasite coevolution, with a focus on bats and their ectoparasites, and birds affected by avian malaria. The group combines fieldwork, laboratory experiments, and molecular analyses, and includes post-docs, PhD students, and technical staff. Collaborations extend to researchers in Bern, Paris, and Spain, fostering an international and interdisciplinary research environment.